0001209191-22-000122.txt : 20220103 0001209191-22-000122.hdr.sgml : 20220103 20220103160324 ACCESSION NUMBER: 0001209191-22-000122 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211230 FILED AS OF DATE: 20220103 DATE AS OF CHANGE: 20220103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Halkias Theodore CENTRAL INDEX KEY: 0001855972 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40332 FILM NUMBER: 22502040 MAIL ADDRESS: STREET 1: C/O AGILON HEALTH, INC. STREET 2: 1 WORLD TRADE CENTER, SUITE 2000 CITY: LONG BEACH STATE: CA ZIP: 90831 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: agilon health, inc. CENTRAL INDEX KEY: 0001831097 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 371915147 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6210 E HWY 290 STREET 2: SUITE 450 CITY: AUSTIN STATE: TX ZIP: 78723 BUSINESS PHONE: 562-256-3800 MAIL ADDRESS: STREET 1: 6210 E HWY 290 STREET 2: SUITE 450 CITY: AUSTIN STATE: TX ZIP: 78723 FORMER COMPANY: FORMER CONFORMED NAME: Agilon Health Topco, Inc. DATE OF NAME CHANGE: 20201103 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-12-30 0 0001831097 agilon health, inc. AGL 0001855972 Halkias Theodore C/O AGILON HEALTH, INC. 1 WORLD TRADE CENTER, SUITE 2000 LONG BEACH CA 90831 0 1 0 0 Chief Business Officer Common Stock 2021-12-30 4 M 0 12113 1.00 A 17547 D Common Stock 2021-12-30 4 S 0 12113 27.54 D 5434 D Common Stock 2021-12-31 4 M 0 1162 1.00 A 6596 D Common Stock 2021-12-31 4 S 0 1162 27.55 D 5434 D Options (Rights to Buy) 1.00 2021-12-30 4 M 0 12113 0.00 D 2027-04-27 Common Stock 12113 1702609 D Options (Rights to Buy) 1.00 2021-12-31 4 M 0 1162 0.00 D 2027-04-27 Common Stock 1162 1701447 D Includes restricted stock units. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, which was adopted prior to September 7, 2021. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $27.50 to $27.64, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $27.50 to $27.70, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. These options were granted on April 27, 2017 and vested in four equal installments on May 15th of each of 2018, 2019, 2020, and 2021. /s/ Lyn Amor Macaraeg, as Attorney-in-Fact 2022-01-03